Sunday, May 7, 8:30 – 10:30am
Light-based treatment strategies for blinding eye disease
Contributing Sections/Groups: AP, BI, CO, EY, GL, IM, LE, LV, MOI, PH, RC, RE, VI
Organizers: Yeni Yucel, Alfredo Dubra
Speakers: Dimitri Azar, Ed Boyden, Randolph Glickman, Daniel V. Palanker, Tony Realini, Arun D. Singh, B.C. Wilson
Ophthalmic light-based therapies harness the power and the precision of light and the specificity of light-activated drugs and nanoparticles. The importance of optical properties of cornea, lens and other eye tissues, in the design of the light-based strategies will be highlighted. The success of this approach depends on international and multidisciplinary efforts to create a continuous dialogue in a common language among physicists and engineers among other basic scientists, as well as clinicians. This symposium brings together experts with perspectives from various disciplines to discuss pathways and opportunities for minimally invasive emerging and future light-based strategies to prevent vision loss from diseases including tumors, corneal disease, glaucoma, and diseases of the retina.
Homologies between the brain and the eye: Can ocular researchers lead the way or are we following our 'brainy' colleagues?
Contributing Sections/Groups: IM, BI, GL, PH, RC
Organizers: Paul McMenamin, Cathy Bowes Rickman, Dan Stamer
Speakers: Claude Bernard, Cathy Bowes Rickman, Sarah Coupland, Britta Engelhardt, Paul McMenamin, Dan Stamer
Many eye researchers may be aware that the retina and pigment derives from an outpouching of the diencephalon of the brain. Many are not aware of the subtle anatomical homologies of components of the eye such as the uveal tract, sclera and the physiological homologies; for example between the aqueous humor with their corresponding elements in the cranial cavity. Many ophthalmologists may have learned basic neuroscience during medical school and professional training but soon become very eye-centric. This symposium will allow participants to connect their ocular focus with current brain research to identify which recent advances in the brain – if any – can be applied to the eye.
Thursday, May 11, 8:30 – 10:30am
Genes and disease: How knowledge of genetics can guide treatment, now and in the future
Contributing Sections/Groups: RC, AP, CO, EY, GL, RE
Organizers: Elliott Sohn, Robert Mullins, Brad Fortune
Speakers: John Fingert, John Flannery, John Guy, Emine Kilic, Caroline Klaver, Tara Moore, David Valle
This symposium will examine how variations that cause disease are discovered, mechanisms of how genetic variations contribute to diseases of the eye, the hurdles to treatment, and the current and future ways that this information can be used to manage and treat disorders of the visual system.
The global problem of antibiotic resistance: Impact on ocular health worldwide and researching alternatives
Contributing Sections/Groups: IM, BI, CL, CO, PH, RE
Organizers: Mary E. Marquart
Speakers: Penny A. Asbell, Gautam Dantas, Prashant Garg, Mike Gilmore, Linda Hazlett
Antibiotic resistance has been steadily rising worldwide despite newer classes of antibiotics being developed. This problem impacts those with any predisposing condition or those undergoing ocular surgery. Clinicians and basic scientists interested in ocular surface and intraocular infections, systemic conditions such as diabetes and immunodeficiencies that predispose patients to ocular infection, and complications arising from ocular surgery, are the target audience of this symposium. This symposium will discuss the current epidemiological trends in resistance worldwide and highlight novel and alternative research strategies that aim to circumvent the problem of antibiotic resistance.